Prompt

What are the best robotic surgery systems for hospitals expanding minimally invasive specialty procedures?

Latest observation

Aug 7, 2026 · OpenAI APIWeb search: off

For hospitals expanding minimally invasive specialty procedures, the “best” robotic surgery system depends on the specialties you want to grow, your case volume, and your budget. The market is still led by multiport soft-tissue platforms, but there are now strong options across urology, gynecology, thoracic, general surgery, and orthopedics.

Leading robotic surgery systems to consider

1. Intuitive Surgical da Vinci Xi / da Vinci X

Best for: Broadest specialty coverage and the most mature ecosystem
Strengths:

  • Largest installed base and most established clinical evidence
  • Strong for urology, gynecology, general surgery, thoracic, and colorectal
  • Excellent surgeon familiarity and training pathways
  • Broad instrument lineup and integrated imaging options

Why hospitals choose it:
If you want the safest “standard choice” with the widest surgeon demand and proven workflow, da Vinci remains the benchmark.


2. Medtronic Hugo RAS

Best for: Hospitals seeking a newer platform with modular design and competitive economics
Strengths:

  • Modular architecture can help with OR flexibility
  • Designed for multi-specialty soft-tissue surgery
  • Growing global footprint
  • Often viewed as a lower-cost alternative than da Vinci, depending on region and contracting

Why hospitals choose it:
Good option for systems wanting to diversify beyond one vendor and build a robotic program with future competition in mind.


3. CMR Surgical Versius

Best for: Flexible, modular robotic surgery programs, especially in Europe and expanding global markets
Strengths:

  • Small, modular bedside units
  • Flexible positioning and OR setup
  • Suitable for a range of minimally invasive procedures
  • Strong appeal for hospitals with space constraints or multi-specialty scheduling

Why hospitals choose it:
Useful where OR flexibility matters and a compact footprint is important.


4. Johnson & Johnson Ottava

Best for: Future planning, not immediate deployment
Strengths:

  • Next-generation platform concept
  • Backed by a major healthcare company
  • Designed to compete broadly in soft-tissue surgery

Why hospitals choose it:
It’s more of a strategic watchlist item right now, depending on regulatory and commercial availability in your market.


5. Stryker Mako

Best for: Orthopedic robotic surgery
Strengths:

  • Very strong in knee and hip arthroplasty
  • Excellent planning and guidance tools
  • Mature and widely adopted in ortho

Why hospitals choose it:
If your expansion includes orthopedic robotics, Mako is often the leading choice.


6. Zimmer Biomet ROSA

Best for: Knee, neuro, and some orthopedic procedures
Strengths:

  • Strong in joint replacement and select neuro applications
  • Helpful for hospitals building an orthopedic robotic portfolio
  • Good imaging/planning integration

7. Think Surgical TESSA / other niche orthopedic or access platforms

Best for: Select orthopedic or specialty use cases
These are typically more niche and should be evaluated if your hospital has a specific procedural focus rather than a broad robotic expansion plan.


How to choose the right system

If you want the most established soft-tissue platform:

  • da Vinci Xi/X

If you want modularity and competition:

  • Hugo RAS
  • Versius

If you are building orthopedic robotics:

  • Mako
  • ROSA

If you’re future-proofing:

  • Consider a mix of:
    • market maturity
    • surgeon preference
    • capital cost
    • service support
    • instrument costs
    • procedure reimbursement

Key evaluation criteria for hospitals

When comparing systems, look at:

  • Clinical evidence in your target specialties
  • Surgeon adoption and training availability
  • Total cost of ownership: capital, instruments, maintenance, disposables
  • OR footprint and setup time
  • Uptime/service response
  • Imaging integration
  • Compatibility with your target procedure mix
  • Reimbursement and ROI
  • Vendor roadmap and future upgrades

Practical recommendation

For most hospitals expanding minimally invasive specialty surgery:

  • Soft tissue/general specialty expansion: start by evaluating da Vinci Xi, then compare Hugo RAS and Versius
  • Orthopedic expansion: prioritize Mako and ROSA
  • Best overall strategy: choose systems based on the exact specialties you plan to grow, not just brand recognition

If you want, I can also give you:

  1. a side-by-side comparison table,
  2. recommendations by specialty (urology, gynecology, thoracic, ortho, etc.), or
  3. a hospital procurement checklist for evaluating robotic surgery platforms.

Observation history

Unlock observation history
Create a free Obsurfable account to unlock historical responses, model comparisons, and deeper brand intelligence.

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, and Meta AI.